DeInnocentes P - Search Results

1

Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency.

Jayanna PK, Bedi D, Gillespie JW, DeInnocentes P, Wang T, Torchilin VP, Bird RC, Petrenko VA. Jayanna PK, et al. Among authors: deinnocentes p. Nanomedicine. 2010 Aug;6(4):538-46. doi: 10.1016/j.nano.2010.01.005. Epub 2010 Feb 4. Nanomedicine. 2010. PMID: 20138246 Free PMC article.

2

Landscape phages and their fusion proteins targeted to breast cancer cells.

Fagbohun OA, Bedi D, Grabchenko NI, Deinnocentes PA, Bird RC, Petrenko VA. Fagbohun OA, et al. Protein Eng Des Sel. 2012 Jun;25(6):271-83. doi: 10.1093/protein/gzs013. Epub 2012 Apr 6. Protein Eng Des Sel. 2012. PMID: 22490956 Free PMC article.

3

Landscape phage ligands for PC3 prostate carcinoma cells.

Jayanna PK, Bedi D, Deinnocentes P, Bird RC, Petrenko VA. Jayanna PK, et al. Among authors: deinnocentes p. Protein Eng Des Sel. 2010 Jun;23(6):423-30. doi: 10.1093/protein/gzq011. Epub 2010 Feb 25. Protein Eng Des Sel. 2010. PMID: 20185523 Free PMC article.

4

Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes.

Bedi D, Musacchio T, Fagbohun OA, Gillespie JW, Deinnocentes P, Bird RC, Bookbinder L, Torchilin VP, Petrenko VA. Bedi D, et al. Among authors: deinnocentes p. Nanomedicine. 2011 Jun;7(3):315-23. doi: 10.1016/j.nano.2010.10.004. Epub 2010 Nov 2. Nanomedicine. 2011. PMID: 21050894 Free PMC article.

5

Characterization of the CDP-like/CTAS-1 binding site in the okadaic acid response element (OARE) of the human CDK1(p34cdc2) promoter.

Bird RC, Deinnocentes P. Bird RC, et al. Among authors: deinnocentes p. Anticancer Res. 2004 May-Jun;24(3a):1469-80. Anticancer Res. 2004. PMID: 15274312 Free article.

6

Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer.

DeInnocentes P, Agarwal P, Bird RC. DeInnocentes P, et al. J Cell Biochem. 2009 Feb 15;106(3):491-505. doi: 10.1002/jcb.22034. J Cell Biochem. 2009. PMID: 19130492

7

An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine.

Bird RC, Deinnocentes P, Church Bird AE, van Ginkel FW, Lindquist J, Smith BF. Bird RC, et al. Among authors: deinnocentes p. Cancer Immunol Immunother. 2011 Jan;60(1):87-97. doi: 10.1007/s00262-010-0921-2. Epub 2010 Nov 11. Cancer Immunol Immunother. 2011. PMID: 21069323 Free PMC article.

8

Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models.

Lutful Kabir FM, DeInnocentes P, Bird RC. Lutful Kabir FM, et al. Among authors: deinnocentes p. J Cell Biochem. 2015 Dec;116(12):2956-69. doi: 10.1002/jcb.25243. J Cell Biochem. 2015. PMID: 26095675

9

An allogeneic hybrid-cell fusion vaccine against canine mammary cancer.

Bird RC, Deinnocentes P, Lenz S, Thacker EE, Curiel DT, Smith BF. Bird RC, et al. Among authors: deinnocentes p. Vet Immunol Immunopathol. 2008 Jun 15;123(3-4):289-304. doi: 10.1016/j.vetimm.2008.02.013. Epub 2008 Feb 26. Vet Immunol Immunopathol. 2008. PMID: 18423623 Clinical Trial.

10

Expression and sequence of canine SIRT2 and p53 genes in canine mammary tumour cells - effects on downstream targets Wip1 and p21/Cip1.

DeInnocentes P, Li LX, Sanchez RL, Bird RC. DeInnocentes P, et al. Vet Comp Oncol. 2006 Sep;4(3):161-77. doi: 10.1111/j.1476-5829.2006.00105.x. Vet Comp Oncol. 2006. PMID: 19754813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters